Synthesis, structural characterization and anticarcinogenic activity of a new Gly-Gly dipeptide derivative: Methyl 2-(2-(5-fluoro-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)acetamido)acetate

Journal of Molecular Structure

Volumn 882, Issue 1-3, 2008, Pages 75-79

  Yin, Ping ^a   Hu, Mao Lin ^a   Hu, Li Chuan ^b  

^a WENZHOU UNIVERSITY   (China)

^b WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Anticarcinogenic activity; Crystal structure; Cyclic voltammograms; Gly Gly dipeptide; Methyl 2 (2 (5 fluoro 2,4 dioxo 3,4 dihydropyrimidin 1(2H) yl)acetamido)acetate; Thermal analysis

Indexed keywords

CRYSTAL STRUCTURE; CYCLIC VOLTAMMETRY; DERIVATIVES; MOLECULAR DYNAMICS; NUCLEAR MAGNETIC RESONANCE; SYNTHESIS (CHEMICAL); THERMOANALYSIS;

ANTICARCINOGENIC ACTIVITY; CYCLIC VOLTAMMOGRAMS; FLUOROURACIL; GLY-GLY DIPEPTIDE;

PEPTIDES;

EID: 44349151434     PISSN: 00222860     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molstruc.2007.09.017     Document Type: Article

References (26)

1. Wang X.Y., Li J., Zhang X.M., Liu Q., Xu Q., and Tan R.X. J. Inorg. Biochem. 94 (2003) 186
2. Cai Bill T.W., Tang X.P., Nagorski J., Brauschweiger P.G., and Wang P.G. Bioorg. Med. Chem. 11 (2003) 4971
3. Wang W.D., and Hu M.L. Chin. J. Struct. Chem. 25 (2006) 562
4. Ouchi T., Hagihara Y., Takahashi K., Takano Y., and Igarushi I. Drug design Disc. 9 (1997) 165
5. Hulme A.T., Price S.L., and Tocher D.A. J. Am. Chem. Soc. 127 (2005) 1116
6. Akalin E., Akyuz S., and Akyuz T. J. Mol. Struct. 834-836 (2007) 477
7. Maeda M., Kajimoto N., Yamaizumi Z., Okamoto Y., Nagahara K., and Takayanagi H. Tetrahedron Lett. 38 (1997) 6841
8. Kataoka K., and Harada A. Adv. Drug. Deliv. Rev. 47 (2001) 113
9. Xiong J., Lei X.X., Hu M.L., Yuan J.X., Cai X.Q., and Kristallogr Z. NCS 221 (2006) 37
10. Tian F.F., Zhou P., and Li Z.L. J. Mol. Struct. 830 (2007) 106
11. Kannappan R., Tooke D.M., Spek A.L., and Reedijk J. J. Mol. Struct. 751 (2005) 55
12. Liu X.J., Chen R.Y., and Liu Y.Y. Chem. J. Chin. U 23 (2002) 1299
13. Bruker. SADABS (Version 2.03), SAINT (Version 6.02), SMART (Version 5.62) and XP (2002), Bruker AXS Inc., Madison, Wisconsin, USA
14. Sheldrick G.M. SHELXS-97, Program for X-Ray Crystal Structure Solution and Refinement (1997), Göttingen University, Germany
15. Jin Z.M., Li L., Li M.C., Hu M.L., and Shen L. Acta Crystallogr. C 60 (2004) o642
16. Grell J., Bernstein J., and Timhofer G. Acta Crystallogr. B 56 (2000) 166
17. Lou B.Y., Yuan D.Q., Han L., Wu B.L., and Hong M.C. Chin. J. Struct. Chem. 24 (2005) 759
18. Lin S.Y., and Chien J.L. Pharm. Res. 20 (2003) 1926
19. Hu T.C., Wang S.L., Chen T.F., and Lin S.Y. J. Pharm. Sci. 91 (2002) 1351
20. Wesolowski M. Drug Devel. Ind. Pharm. 11 (1985) 493
21. Sperandeo N.R., Karlsson A., Cuffini S., Pagola S., and Stephens P.W. AAPS Pharm. Sci. Technol. 6 (2005) E655
22. Mossman T. J. Immunol. Methods 65 (1983) 55
23. Skehan P., Storeng R., Scudiero D., Monks A., McMahon J., Vistica D., Warren H.J., Bokesch H., Kenney S., and Boyd M.R. J. Natl. Cancer Inst. 82 (1990) 1107
24. Rao G.W., and Hu W.X. Bioorg. Med. Chem. Lett. 16 (2006) 3702
25. Wang J., Lin M., and Villa V. Analyst 112 (1987) 247
26. Guerrieri A., Cataldi T., Palmisano F., and Zambonin P. Anal. Chim. Acta 207 (1988) 183